Bebtelovimab in the Real World: Promise and Fulfillment
J Infect Dis
.
2022 Nov 11;226(10):1681-1682.
doi: 10.1093/infdis/jiac347.
Authors
Robin K Avery
1
,
M Veronica Dioverti Prono
1
Affiliation
1
Department of Medicine, Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, USA.
PMID:
36124710
PMCID:
PMC9494461
DOI:
10.1093/infdis/jiac347
No abstract available
Keywords:
SARS-CoV-2; bebtelovimab; nirmatrelvir-ritonavir.
Publication types
Editorial
Comment
MeSH terms
COVID-19 Drug Treatment
COVID-19*
Humans
Ritonavir
SARS-CoV-2*
Substances
Ritonavir
bebtelovimab